Follow the First Wave BioPharma, Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was disclosed on 3 April 2024 (Cession). Among the most active insiders: SAPIRSTEIN JAMES. The full history is free.
29
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€38,307
14 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate First Wave BioPharma, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
38Σ signal
Buys n/a€38,307 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
First Wave BioPharma, Inc. is a biopharmaceutical company focused on developing treatments for gastrointestinal diseases. It is listed on the NASDAQ under the ticker FWBI.